"The National Institutes of Health has awarded four grants for up to four years to multidisciplinary research teams to explore the use of genome sequencing in medical care. The awards total approximately $6.7 million in the first year and, if fund"...
- Inform patients that ELELYSO is administered under the supervision of a healthcare professional as an intravenous infusion every other week. The infusion typically takes 60 to 120 minutes.
- Advise patients that ELELYSO may cause severe allergic reactions or infusion reactions. Patients should be counseled that they should be carefully re-evaluated for treatment with ELELYSO if serious allergic reactions occur. Patients should also be counseled that infusion reactions can usually be managed by slowing the infusion rate, treatment with medications such as antihistamines, antipyretics and/or corticosteroids, and/or stopping and resuming treatment with decreased infusion rate. Patients should also be counseled that pre-treatment with antihistamines and/or corticosteroids may prevent subsequent reactions [see WARNINGS AND PRECAUTIONS].
- Advise patients to report any adverse reactions while on ELELYSO treatment.
Last reviewed on RxList: 5/14/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Elelyso Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.